- Home
- GRCE vs TPCS Comparison
GRCE vs TPCS Comparison
Compare GRCE & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- TPCS
- Stock Information
- Founded
- GRCE 2002
- TPCS 1956
- Country
- GRCE United States
- TPCS United States
- Employees
- GRCE N/A
- TPCS N/A
- Industry
- GRCE
- TPCS Metal Fabrications
- Sector
- GRCE
- TPCS Industrials
- Exchange
- GRCE NYSE
- TPCS Nasdaq
- Market Cap
- GRCE 42.1M
- TPCS 42.6M
- IPO Year
- GRCE N/A
- TPCS N/A
- Fundamental
- Price
- GRCE $2.94
- TPCS $3.71
- Analyst Decision
- GRCE Strong Buy
- TPCS
- Analyst Count
- GRCE 1
- TPCS 0
- Target Price
- GRCE $12.00
- TPCS N/A
- AVG Volume (30 Days)
- GRCE 53.8K
- TPCS 30.4K
- Earning Date
- GRCE 06-23-2025
- TPCS 04-08-2025
- Dividend Yield
- GRCE N/A
- TPCS N/A
- EPS Growth
- GRCE N/A
- TPCS N/A
- EPS
- GRCE N/A
- TPCS N/A
- Revenue
- GRCE N/A
- TPCS $33,154,058.00
- Revenue This Year
- GRCE N/A
- TPCS N/A
- Revenue Next Year
- GRCE N/A
- TPCS N/A
- P/E Ratio
- GRCE N/A
- TPCS N/A
- Revenue Growth
- GRCE N/A
- TPCS 8.71
- 52 Week Low
- GRCE $1.75
- TPCS $2.05
- 52 Week High
- GRCE $4.97
- TPCS $4.42
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- TPCS 52.13
- Support Level
- GRCE N/A
- TPCS $3.52
- Resistance Level
- GRCE N/A
- TPCS $3.88
- Average True Range (ATR)
- GRCE 0.00
- TPCS 0.23
- MACD
- GRCE 0.00
- TPCS -0.01
- Stochastic Oscillator
- GRCE 0.00
- TPCS 51.25
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.